Online, 29/09 – 2/10, 2021.
Dr Malvehy presented iToBoS in the EADV (European Academy of Dermatology and Venereology) Congress. The event showcases the latest innovations in Dermatology and Venereology and provides a platform for deep scientific exchange with the dermato-venereology community.
The congress is also the occasion to celebrate the EADV’s unique achievements and important milestones over the past more than 30 years that have made the Academy and indeed the Congress what they are today.
EADV is the leading community to further the knowledge of health professionals and advocates in the field of dermatology and venereology. It is dedicated to advancing patient care, education and research in the field of dermatology and venereology by providing a unique platform to bring people together and share ideas. The vision of the EADV is to be the premier European Dermato-Venereology Society with the important aims of leading to improved quality patient care, continuing medical education for all Dermato-Venereologists within Europe, and advocacy on behalf of the speciality and patients.
Dr Josep Malvehy represented iToBoS project in the EADV 30th Congress. His participation included the following:
- Controversies, on September 30th, 2021.
- Adjuvant and neoadjuvant cancer therapies. Reviews and updates, on October 1st, 2021.
- Introduction, on September 30th, 2021.
- Adjuvant therapies in stage III melanomas, on October 1st, 2021.
- Teledermatology, AI and the future of skin cancer care, on October 2nd, 2021.
Learn more at EADV Congress 2021.